NeuroSense Therapeutics Ltd.
NRSN | NASDAQ
$1.99
-$0.14 (-6.57%)
At close: Oct 30, 2026, 4:00 PM ET
$1.99
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
TTM Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -6.42M | -3.21M | -8.66K | -7.16K | -10.21K | -10.19K | -7.25K | -11.62K | -10.11K | -9.63K | -13.41K | -11.67K | -10.49K | -9.29K | -7.19K | -4.63K | -4.04K | -1.11M | -2.21M | -2.52M | -2.83M | -1.73M | -622K | -311K |
Depreciation & Amortization | 8K | 4K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.5K | 3K | 3K | 3K | 1.5K | n/a | n/a |
Stock-Based Compensation | 1.83M | 917.86K | 557 | 710 | 557 | 1.54K | 59 | 1.54K | 1.54K | 1.73K | 704 | 1.73K | 1.73K | 3.82K | 4K | 3.82K | 3.82K | 907K | 1.82M | 1.94M | 2.06M | 1.15M | 247K | 123.5K |
Other Working Capital | 1.38M | 692.16K | 160.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.5K | 39K | 45K | 51K | 31.5K | 12K | 6K |
Other Non-Cash Items | -337.83K | -166.58K | 5.87K | 6.45K | 9.65K | 8.65K | 7.2K | 10.09K | 8.57K | 7.9K | 12.71K | 9.94K | 8.76K | 5.47K | 3.19K | 814 | 223 | 7.44K | 7.42K | 20.62K | 30K | 26.5K | 23K | 11.5K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.24M | 621.73K | 231 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21K | 42K | 40.5K | 39K | 18K | -3K | -1.5K |
Operating Cash Flow | -3.67M | -1.84M | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -170K | -340K | -517.5K | -695K | -525K | -355K | -177.5K |
Capital Expenditures | -3K | -1.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5K | -5K | -7K | -9K | -6.5K | -4K | -2K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 7.99K | 3.99K | -6.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 4.99K | 2.49K | -6.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.5K | -5K | -7K | -9K | -6.5K | -4K | -2K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.13M | 1.57M | 650.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 508K | 508K | 508K | 254K |
Financial Cash Flow | 3.13M | 1.57M | 650.50 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 254K | 508K | 508K | 508K | 254K |
Net Cash Flow | -501.36K | -251.36K | -1.36K | n/a | n/a | -2.12M | -4.45M | 1.28M | -899K | 362K | 2.76M | -7.4M | -5.22M | -4.37M | -4.43M | n/a | n/a | -172.5K | -345K | -270.5K | -196K | -23.5K | 149K | 74.5K |
Free Cash Flow | -3.68M | -1.84M | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -172.5K | -345K | -524.5K | -704K | -531.5K | -359K | -179.5K |
Adj. Free Cash Flow | -5.51M | -2.76M | -2.56K | -710 | -557 | -1.54K | -59 | -1.54K | -1.54K | -1.73K | -704 | -1.73K | -1.73K | -3.82K | -4K | -3.82K | -3.82K | -1.08M | -2.16M | -2.46M | -2.77M | -1.69M | -606K | -303K |
Maintenance CapEx | -3K | -1.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.5K | -3K | -3K | -3K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -2K | -4K | -6K | n/a | n/a | n/a |
Owner Earnings | -3.68M | -1.84M | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -171.5K | -343K | -520.5K | -698K | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove NRSN